Content deleted Content added
Mycobacterium avium and M. avium complex redirect here (redirect loop) |
→Description: Space Tags: Mobile edit Mobile web edit Advanced mobile edit |
||
(40 intermediate revisions by 27 users not shown) | |||
Line 1:
{{Short description|Group of bacteria}}
{{Distinguish|Mycobacterium tuberculosis complex}}{{italic title|string=Mycobacterium avium}}
{{Taxobox
| name = ''Mycobacterium avium'' complex
| ___domain = [[Bacteria]]
| phylum = [[
|
|
| familia = [[Mycobacteriaceae]]
| genus = ''[[Mycobacterium]]''
Line 13 ⟶ 14:
| binomial2 = ''Mycobacterium avium''
| binomial2_authority = Chester 1901 emend. Thorel et al. 1990
}}
'''''Mycobacterium avium
==Description==
[[File:Slant tubes of Löwenstein-Jensen medium with control, M tuberculosis, M avium and M gordonae.jpg|thumb|150px|Slant tubes of [[Löwenstein-Jensen medium]]. From left to right:<br>- Negative control<br>- ''[[M. tuberculosis]]'': Dry-appearing colonies<br>- ''Mycobacterium avium complex'': Wet-appearing colonies<br>- ''[[M. gordonae]]'': Yellowish colonies]]
In the [[Runyon classification]],
'''Colony characteristics'''
* Usually, colonies are smooth, rarely rough, and
'''Physiology'''
* Growth on [[Löwenstein-Jensen]] medium and [[Middlebrook 7H10 Agar|Middlebrook 7H10 agar]] occurs at 37
* The complex can be (but is not often) resistant to [[isoniazid]], [[ethambutol]], [[rifampin]], and [[streptomycin]].<ref name="pmid29054853">{{cite journal | vauthors = Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA | title = British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) | journal = Thorax | volume = 72 | issue = Suppl 2 | pages = ii1–ii64 | date = November 2017 | pmid = 29054853 | doi = 10.1136/thoraxjnl-2017-210927 | doi-access = free }}</ref>
'''Differential characteristics'''
* ''M. intracellulare'' and ''
* Remarkable [[Internal transcribed spacer|ITS]] heterogeneity is seen within different ''M. intracellulare'' isolates.
== Species ==
* ''[[Mycobacterium avium avium|Mycobacterium avium]]''
** ''[[Mycobacterium avium subsp. paratuberculosis]]''
==Type strains==
* ''M. intracellulare'' type strains include [[American Type Culture Collection|ATCC]] 13950, CCUG 28005, CIP 104243, DSM 43223, JCM 6384, and NCTC 13025.<ref>[http://bacdive.dsmz.de/index.php?search=8403&submit=Search Type strain of ''Mycobacterium intracellulare'' at Bac''Dive'' - the Bacterial Diversity Metadatabase]</ref>
* ''M. avium'' type strains include
▲''M. avium'' type strains include [[American Type Culture Collection|ATCC]] 25291, DSM 44156, and TMC 724.<ref>[http://bacdive.dsmz.de/index.php?site=search&rd=8419 Type strain of ''Mycobacterium avium'' at Bac''Dive'' - the Bacterial Diversity Metadatabase]</ref>
==Human health==
MAC bacteria enter most people's body when inhaled into the lungs or swallowed, but only cause infection in those who are [[immunocompromised]] or who have severe [[lung disease]] such as those with [[cystic fibrosis]] or [[chronic obstructive lung disease]] (COPD).<ref name=":0" /> [[Mycobacterium avium-intracellulare infection|MAC infection]] can cause
During the last decade ''Mycobacterium chimaera'' (see below) infections following cardiothoracic surgery, especially open-heart surgery, have been increasingly reported worldwide.<ref>{{Cite journal |last1=Riccardi |first1=Niccolò |last2=Monticelli |first2=Jacopo |last3=Antonello |first3=Roberta Maria |last4=Luzzati |first4=Roberto |last5=Gabrielli |first5=Marco |last6=Ferrarese |first6=Maurizio |last7=Codecasa |first7=Luigi |last8=Di Bella |first8=Stefano |last9=Giacobbe |first9=Daniele Roberto |date=2020 |title=Mycobacterium chimaera infections: An update |url=https://linkinghub.elsevier.com/retrieve/pii/S1341321X19303459 |journal=Journal of Infection and Chemotherapy |language=en |volume=26 |issue=3 |pages=199–205 |doi=10.1016/j.jiac.2019.11.004|pmid=31843377 |url-access=subscription }}</ref> Infections usually involve the respiratory system. ''Mycobacterium chimaera'' is acquired during cardiopulmonary bypass via bioaerosols emitted from contaminated heater-cooler units water systems. Due to nonspecific symptoms and long latency, postoperative ''Mycobacterium chimaera'' infections may not be promptly diagnosed and treated, and may become life-threatening.
==History==
In 2004, Tortoli et al. proposed the name ''M. chimaera'' for strains that a reverse hybridization–based line probe assay suggested belonged to MAIS (''M. avium–M. intracellulare–M. scrofulaceum'' group), but were different from ''M. avium'', ''M. intracellulare'', or ''M. scrofulaceum''. The new species name comes from the [[chimera (mythology)|
==References==
{{
==External links==
* {{MeshName|Mycobacterium avium Complex}}
{{Gram-positive actinobacteria diseases}}
{{Mycobacteria}}
{{Taxonbar|from=Q3311330}}
{{DEFAULTSORT:Mycobacterium Intracellulare}}
[[Category:Acid
[[Category:Nontuberculous mycobacteria|avium complex]]
[[Category:Bacteria described in 1965]]
[[Category:Pathogenic bacteria]]
|